Abstract
Antibodies that react with self-molecules occur in healthy individuals and are referred to as natural antibodies or autoantibodies. Natural autoantibodies are mainly IgM, are encoded by unmutated V(D)J genes and display a moderate affinity for self-antigens. They provide a first line of defense against infections, probably serve housekeeping functions and contribute to the homeostasis of the immune system. By contrast, high-affinity, somatically mutated IgG autoantibodies reflect a pathologic process whereby homeostatic pathways related to cell clearance, antigen-receptor signaling or cell effector functions are disturbed. In some autoimmune disorders, autoantibodies might be present before disease onset, show remarkable specificity and serve as biomarkers providing an opportunity for diagnosis and therapeutic intervention. In organ-specific autoimmune diseases, such as myasthenia gravis or pemphigus, autoantibodies directly bind to and injure target organs. In systemic autoimmune diseases, autoantibodies react with free molecules, such as phospholipids, as well as cell surface and nucleoprotein antigens, forming pathogenic antigen–antibody (immune) complexes. These autoantibodies injure tissues and organs through engagement of FcγR activation of complement as well as internalization and activation of Toll-like receptors. Activation of intracellular Toll-like receptors in plasmacytoid dendritic cells leads to the production of type I interferon, whereas engagement of intracellular Toll-like receptors on antigen-presenting cells stimulates cell activation and the production of other inflammatory cytokines. Thus, immune complexes might perpetuate a positive feedback loop amplifying inflammatory responses.
Key Points
-
Natural antibodies or autoantibodies, particularly IgM, that react with self-molecules occur in normal individuals and display a moderate affinity but high avidity for self-antigens
-
High-affinity, somatically mutated, class-switched IgG autoantibodies reflect a pathologic process in which homeostatic pathways related to cell clearance, antigen-receptor signaling or cell effector functions are disturbed
-
The mechanisms involved in immune-complex-mediated tissue injury include engagement of FcγRs and activation of complement, as well as internalization and activation of Toll-like receptors
-
Autoantibodies might be detectable long before disease onset and serve as biomarkers enabling diagnosis and targeting of therapeutic intervention
-
In organ-specific autoimmune diseases, autoantibodies directly injure target organs; in systemic autoimmune diseases, they can also bind to different self-molecules and cause disease through the formation of immune complexes
-
Research is needed to clarify why certain antigens are targeted in different autoimmune diseases and how some antibodies activate, whereas others inhibit, immune responses
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Casali P and Schettino EW (1996) Structure and function of natural antibodies. Curr Top Microbiol Immunol 210: 167–179
Carroll MC (1998) The lupus paradox. Nat Genet 19: 3–59
Carroll MC (1998) The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 16: 545–568
Zhou ZH et al. (2007) The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1: 51–61
Baxendale HE et al. (2008) Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease. Clin Exp Immunol 151: 51–60
Yurasov S and Nussenzweig MC (2007) Regulation of autoreactive antibodies. Curr Opin Rheumatol 19: 421–426
Harindranath N et al. (1993) Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli β-galactosidase. Int Immunol 5: 1523–1533
Phillips-Quagliata JM et al. (2001) IgG2a and IgA co-expression by the natural autoantibody-producing murine B lymphoma T560. Autoimmunity 33: 181–197
Casali P et al. (1987) Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ (CD5+) B-cell subset. Science 236: 77–81
Casali P and Notkins AL (1989) CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 10: 364–368
Casali P and Notkins AL (1989) Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol 7: 513–535
Duan B and Morel L (2006) Role of B-1a cells in autoimmunity. Autoimmun Rev 5: 403–408
Mohan C et al. (1998) Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum 41: 1652–1662
Casali P (1990) Polyclonal B cell activation and antigen-driven antibody response as mechanisms of autoantibody production in systemic lupus erythematosus. Autoimmunity 5: 147–150
Kasaian MT and Casali P (1993) Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition. Autoimmunity 15: 315–329
Kasaian MT and Casali P (1995) B-1 cellular origin and VH segment structure of IgG, IgA, and IgM anti-DNA autoantibodies in patients with systemic lupus erythematosus. Ann NY Acad Sci 764: 410–423
Chai SK et al. (1994) Natural autoantibodies. Adv Exp Med Biol 347: 147–159
Schettino EW et al. (1996) Structure-function relation in natural and disease-associated human autoantibodies. In The Antibodies, (Vol 2) 155–203 (Eds Zanetti M and Capra JD) Amsterdam: Harwood Academic Publishers
Schettino EW et al. (1997) VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection. J Immunol 158: 2477–2489
Carroll MC and Prodeus AP (1998) Linkages of innate and adaptive immunity. Curr Opin Immunol 10: 36–40
Carroll MC and Holers VM (2005) Innate autoimmunity. Adv Immunol 86: 137–157
Fleming SD (2006) Natural antibodies, autoantibodies and complement activation in tissue injury. Autoimmunity 39: 379–386
Zhang M and Carroll MC (2007) Natural antibody mediated innate autoimmune response. Mol Immunol 44: 103–110
Harindranath N et al. (1991) Complete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient. Int Immunol 3: 865–875
Mantovani L et al. (1993) Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors. J Immunol 151: 473–488
Kasaian MT et al. (1994) Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus. J Immunol 152: 3137–3151
Ichiyoshi Y and Casali P (1995) Analysis of the structural correlates for self-antigen binding by natural and disease-related autoantibodies. In vitro expression of recombinant and/or mutagenized human IgG. Ann NY Acad Sci 764: 328–341
Ichiyoshi Y et al. (1995) A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin specific “germ-line” natural antibody template. J Immunol 154: 226–238
Li Z et al. (2000) Structure-function analysis of a lupus anti-DNA autoantibody: central role of the heavy chain complementarity-determining region 3 Arg in binding of double- and single-stranded DNA. Eur J Immunol 30: 2015–2226
Duquerroy S et al. (2007) Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation. J Mol Biol 368: 1321–1331
Arnold LW et al. (1994) Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J Exp Med 179: 1585–1595
Ikematsu H et al. (1994) VH and Vκ segment structure of anti-insulin IgG autoantibodies in patients with insulin-dependent diabetes mellitus. Evidence for somatic selection. J Immunol 152: 1430–1441
Ichiyoshi Y and Casali P (1994) Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain variable gene segments. J Exp Med 180: 885–895
Ikematsu W et al. (1998) Human anti-cardiolipin IgG monoclonal autoantibodies cause placental thrombosis and fetal loss in BALB/c mice. Arthritis Rheum 41: 1026–1039
Hardy RR (2006) B-1 B cell development. J Immunol 177: 2749–2754
Honjo T et al. (2004) AID: how does it aid antibody diversity? Immunity 20: 659–668
Casali P et al. (2006) DNA repair in antibody somatic hypermutation. Trends Immunol 27: 313–321
Diaz M and Casali P (2002) Somatic immunoglobulin hypermutation. Curr Opin Immunol 14: 235–240
Straus SE et al. (1999) An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med 130: 591–601
Peng Y et al. (2005) The role of IgM antibodies in the recognition and clearance of apoptotic cells. Mol Immunol 42: 781–787
Peng Y et al. (2007) Innate and adaptive immune response to apoptotic cells. J Autoimmun 29: 303–309
Sakaguchi N et al. (2003) Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426: 454–460
Casciola-Rosen L et al. (1999) Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 190: 815–826
Klareskog L et al. (2006) Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol 18: 867–875
Theofilopoulos AN et al. (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23: 307–336
Martin DA and Elkon KB (2005) Autoantibodies make a U-turn: the toll hypothesis for autoantibody specificity. J Exp Med 202: 1465–1469
Baccala R et al. (2007) TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13: 543–551
Wildbaum G et al. (2003) Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity. Immunity 19: 679–688
Cochrane CG and Koffler D (1973) Immune complex disease in experimental animals and man. Adv Immunol 16: 185–264
Koffler D et al. (1967) Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 126: 607–624
Girardi G et al. (2006) The complement system in the pathophysiology of pregnancy. Mol Immunol 43: 68–77
Monach PA et al. (2004) The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv Immunol 82: 217–248
Clynes R et al. (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279: 1052–1054
Bolland S and Ravetch JV (2000) Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13: 277–285
Nimmerjahn F and Ravetch JV (2005) Divergent immunoglobulin gamma subclass activity through selective Fc receptor binding. Science 310: 1510–1512
Arbuckle MR et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526–1533
Buyon JP and Winchester R (1990) Congenital complete heart block. A human model of passively acquired autoimmune injury. Arthritis Rheum 33: 609–614
Targoff IN (2000) Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol 12: 475–481
DeGiorgio LA et al. (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7: 1189–1193
Zhao ZS et al. (1998) Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279: 1344–1347
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Elkon, K., Casali, P. Nature and functions of autoantibodies. Nat Rev Rheumatol 4, 491–498 (2008). https://doi.org/10.1038/ncprheum0895
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0895
This article is cited by
-
Identification of biomarker candidates for exfoliative glaucoma from autoimmunity profiling
BMC Ophthalmology (2024)
-
Long-term effects of SARS-CoV-2 infection in hospitalized children: findings from an Italian single-center study
Italian Journal of Pediatrics (2024)
-
Immunpathogenese des systemischen Lupus erythematodes
Zeitschrift für Rheumatologie (2024)
-
Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) – protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)
BMC Infectious Diseases (2024)
-
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Nature Reviews Immunology (2023)